Novigenix Company

Generate insights from the response of the immune system to detect disease as early as possible and to provide precision medicine solutions
Technology: Immunotherapy
Industry: Preclinical/Clinical Trials (CRO)
Headquarters: Epalinges, Vaud
Founded Date: 2014
Employees Number: 11-50
Investors Number: 1
Total Funding: $1M
Estimated Revenue: $1M to $10M
Last Funding Type: Grant

Visit Website
valentin.matillon@novigenix.com
Register and Claim Ownership